Sandra M. Hayes

Distinct Structure and Signaling Potential of the γδTCR Complex

Abstract αβ and γδ T cells are distinguished by the clonotypic subunits contained within their TCRs. Although the αβTCR has been well characterized, much less is known about the γδTCR. Here, we report that, unlike αβTCRs, most γδTCRs expressed on ex vivo γδ T cells lack CD3δ. Despite this structural difference, signal transduction by the γδTCR is superior to that of the αβTCR, as measured by its ability to induce calcium mobilization, ERK activation, and cellular proliferation. Additionally, the TCR complexes expressed on primary γδ T cells contain only ζζ homodimers; however, following activation and expansion, FcϵR1 γ is expressed and is included in the γδTCR complex. These results reveal fundamental differences in the primary structure and signaling potential of the αβ- and γδTCR complexes.

Strength of signal: a fundamental mechanism for cell fate specification

Summary:u2002 How equipotent cells develop into complex tissues containing many diverse cell types is still a mystery. However, evidence is accumulating from different tissue systems in multiple organisms that many of the specific receptor families known to regulate cell fate decisions target conserved signaling pathways. A mechanism for preserving specificity in the cellular response that has emerged from these studies is one in which quantitative differences in receptor signaling regulate the cell fate decision. A signal strength model has recently gained support as a means to explain αβ/γδ lineage commitment. In this review, we compare the αβ/γδ fate decision with other cell fate decisions that occur outside of the lymphoid system to attain a better picture of the quantitative signaling mechanism for cell fate specification.

Stoichiometry of the murine γδ T cell receptor

The T cell receptor for antigen (TCR) complex is organized into two functional domains: the antigen-binding clonotypic heterodimer and the signal-transducing invariant CD3 and TCRζ chains. In most vertebrates, there are two different clonotypic heterodimers (TCRαβ and TCRγδ) that define the αβ and γδ T cell lineages, respectively. αβ- and γδTCRs also differ in their invariant chain subunit composition, in that αβTCRs contain CD3γɛ and CD3δɛ dimers, whereas γδTCRs contain only CD3γɛ dimers. This difference in subunit composition of the αβ- and γδTCRs raises the question of whether the stoichiometries of these receptor complexes are different. As the stoichiometry of the murine γδTCR has not been previously investigated, we used two quantitative immunofluorescent approaches to determine the valency of TCRγδ heterodimers and CD3γɛ dimers in surface murine γδTCR complexes. Our results support a model of murine γδTCR stoichiometry in which there are two CD3γɛ dimers for every TCRγδ heterodimer.

Activation-induced Modification in the CD3 Complex of the γδ T Cell Receptor

The T cell antigen receptor complexes expressed on αβ and γδ T cells differ not only in their respective clonotypic heterodimers but also in the subunit composition of their CD3 complexes. The γδ T cell receptors (TCRs) expressed on ex vivo γδ T cells lack CD3δ, whereas αβ TCRs contain CD3δ. While this result correlates with the phenotype of CD3δ−/− mice, in which γδ T cell development is unaffected, it is inconsistent with the results of previous studies reporting that CD3δ is a component of the γδ TCR. Since earlier studies examined the subunit composition of γδ TCRs expressed on activated and expanded peripheral γδ T cells or γδ TCR+ intestinal intraepithelial lymphocytes, we hypothesized that activation and expansion may lead to changes in the CD3 subunit composition of the γδ TCR. Here, we report that activation and expansion do in fact result in the inclusion of a protein, comparable in mass and mobility to CD3δ, in the γδ TCR. Further analyses revealed that this protein is not CD3δ, but instead is a differentially glycosylated form of CD3γ. These results provide further evidence for a major difference in the subunit composition of αβ- and γδ TCR complexes and raise the possibility that modification of CD3γ may have important functional consequences in activated γδ T cells.

Thymic involution in viable motheaten (me(v)) mice is associated with a loss of intrathymic precursor activity.

Mice homozygous for the viable motheaten (meυ) allele manifest abnormalities in thymocytopoiesis, are severely immunodeficient, and develop autoimmune disorders early in life. Premature thymic involution occurs in meυ/meυ mice, and their bone marrow prothymocytes are unable to repopulate the thymus of adoptive recipients following intravenous (i.v.) transfer. However, analysis of thymocytopoiesis following intrathymic (i.t.) adoptive transfer of bone marrow from meυ/meυ mice demonstrates the presence of normal numbers of prothymocytes. To investigate intrathymic development in meυ/meυ mice, we determined intrathymic precursor cell number and activity. Dual labeling analyses showed that an involuted meυ/meυ thymus is relatively enriched (fivefold) in CD4– CD8– thymocytes (intrathymic precursor phenotype) compared with wild-type (+/+) thymus. However, thymocytes from meυ/meυ mice were deficient in precursor activity when adoptively transferred i.t. into irradiated recipients. Thymocytes recovered from the involuted thymus of aged or steroid-treated normal mice also displayed reduced precursor activity. However, the phenotypic profile of thymocyte subsets from steroid-treated mice was enriched in single positive cells (mature phenotype) and was distinctly different from the subset distribution of thymocytes in meυ/meυ and aged mice. These results suggest that intrathymic precursor activity in meυ/meυ mice is decreased, and may be reflective of decreased prothymocyte seeding to the thymus in vivo, In addition, the results suggest that the thymic involution in meυ/meυ mice is not due solely to effects of corticosteroids.